A randomized comparison of misoprostol to intrauterine instillation of hypertonic saline plus a prostaglandin F2α analogue for second-trimester induction termination in Uzbekistan

Contraception

Volumn 76, Issue 6, 2007, Pages 461-466

  Kapp, Nathalie ^a   Todd, Catherine S ^b   Yadgarova, Klara T ^c   Alibayeva, Gulchaekra ^c   Nazarova, Dilyora ^c   Loza, Oralia ^b   Babadjanova, Guldjahan S ^d  

^a BOSTON MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Ministry of Health Uzbekistan   (Uzbekistan)

^d TASHKENT MEDICAL ACADEMY   (Uzbekistan)

Author keywords

Abortion acceptability; Misoprostol; Second trimester abortion; Uzbekistan

Indexed keywords

CLOPROSTENOL; MISOPROSTOL; PARACETAMOL; PROSTAGLANDIN F2 ALPHA DERIVATIVE; SODIUM CHLORIDE;

ADULT; ANAMNESIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFICACY; FEMALE; GESTATIONAL AGE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PAIN; PARITY; PATIENT SATISFACTION; PLACENTA; PREGNANCY TERMINATION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; UZBEKISTAN;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, THERAPEUTIC; ADMINISTRATION, INTRAVAGINAL; ADULT; CLOPROSTENOL; DEVELOPING COUNTRIES; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; LUTEOLYTIC AGENTS; MISOPROSTOL; PATIENT SATISFACTION; PREGNANCY; PREGNANCY TRIMESTER, SECOND; SALINE SOLUTION, HYPERTONIC; TREATMENT OUTCOME;

EID: 36549026005     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2007.08.004     Document Type: Article

References (26)

1. Alan Guttmacher Institute. Facts in brief: induced abortion worldwide. Available at:. http://www.agi-usa.org/pubs/fb_0599.html Accessed 4/2007
2. Marston C., and Cleland J. Relationships between contraception and abortion: a review of the evidence. Int Fam Plann Perspect 29 (2003) 6-13
3. Population Resource Center. Executive summary: recent trends in abortion and contraception in twelve countries. Available at:. http://www.prcdc.org/Recent_Trends_in_Abortion.pdf Accessed 4/2007
4. Grimes D.A., and Schulz K.F. Morbidity and mortality from second-trimester abortions. J Reprod Med 30 (1985) 505-514
5. Grimes D.A., Schulz K.F., Cates W., and Tyler C.W. Methods of midtrimester terminations, which is safest?. Int J Gynaecol Obstet 15 (1977) 184-188
6. Herndon J., Strauss L.T., Whitehead S., Parker W.Y., Bartlett L., and Zane S. Abortion surveillance - United States, 1998. Morb Mortal Wkly Rep Surveill Summ 51 (2002) 1-32
7. Cates Jr. W., Schulz K.F., Grimes D.A., et al. Dilatation and evacuation procedures and second-trimester abortions. The role of physician skill and hospital setting. JAMA 248 (1982) 559-563
8. Cates Jr. W., Schulz K.F., and Grimes D.A. Dilatation and evacuation for induced abortion in developing countries: advantages and disadvantages. Stud Fam Plann 11 (1980) 128-133
9. Binkin N.J., Schulz K.F., Grimes D.A., and Cates Jr. W. Urea-prostaglandin versus hypertonic saline for instillation abortion. Am J Obstet Gynecol 146 (1983) 947-952
10. Borenstein R., Ashkenazy M., and Lancet M. Early complications and sequence of pregnancy interruption with hypertonic saline. Int J Fertil 25 (1980) 88-93
11. Grimes D.A., Smith M.S., and Witham A.D. Mifepristone and misoprostol versus dilation and evacuation for midtrimester abortion: a pilot randomised controlled trial. BJOG 11 (2004) 148-153
12. Goldberg A.B., Greenberg M.B., and Darney P.D. Misoprostol and pregnancy. N Engl J Med 344 (2001) 38-60
13. DeLoach L.J., Higgins M.S., Caplan A.B., and Stiff J.L. The visual analog scale in the immediate postoperative period: intraparticipant variability and correlation with a numeric scale. Anesth Analg 86 (1998) 102-106
14. Allahbadia G. Comparative study of midtrimester termination of pregnancy using hypertonic saline, ethacridine lactate, prostaglandin analogue and iodine-saline. J Indian Med Assoc 90 (1992) 237-239
15. Muzsnai D., and Kerenyi T. Use of prostaglandin, hypertonic saline and oxytocin for second-trimester abortion. Eur J Obstet Gynecol Reprod Biol 9 (1979) 385-389
16. 2 gel: an analysis of efficacy and complications. J Med Assoc Thai 77 (1994) 148-152
17. Herabutya Y., Chanrachakul B., and Punyavachir P. A randomised controlled trial of 6 and 12 hourly administration of vaginal misoprostol for second trimester pregnancy termination. BJOG 112 (2005) 1297-1301
18. Bebbington M., Kent N., Lim K., et al. A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination. Am J Obstet Gynecol 187 (2002) 853-857
19. Yilmaz B., Kelekci S., Ertas I., et al. Misoprostol moistened with acetic acid or saline for second trimester pregnancy termination: a randomized prospective double-blind trial. Hum Reprod 20 (2005) 3067-3071
20. Borgatta L., Chen A., Vragovic O., Stubblefield P., and Magloire C.A. A randomized clinical trial of the addition of laminaria to misoprostol and hypertonic saline for second-trimester induction abortion. Contraception 72 (2005) 358-361
21. 2 for termination of second-trimester pregnancy. N Engl J Med 331 (1994) 290-293
22. Choudhary N., Saha S.C., and Gopalan S. Abortion procedures in a tertiary care institution in India. Int J Gynaecol Obstet 91 (2005) 81-86
23. Dilbaz S., Caliskan E., Dilbaz B., and Kahraman B.G. Frequent low-dose misoprostol for termination of second-trimester pregnancy. Eur J Contracept Reprod Health Care 1 (2004) 11-15
24. Jain J.K., Harwood B., Meckstroth K.R., and Mishell D.R. Early pregnancy termination with vaginal misoprostol combined with loperamide and acetaminophen prophylaxis. Contraception 63 (2001) 217-221
25. Rayburn W., Shukla U., Stetson P., and Piehl E. Acetaminophen pharmacokinetics: comparison between pregnant and nonpregnant women. Am J Obstet Gynecol 155 (1986) 1353-1356
26. Zieman M., Fong S.K., Benowitz N.L., Banskter D., and Darney P.D. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 90 (1997) 88-92